Editorial
doi: 10.1200/JCO.2006.10.2210.
Docetaxel, cisplatin, and fluorouracil in gastric cancer: does the punishment fit the crime?
- PMID: 17664464
- DOI: 10.1200/JCO.2006.10.2210
Item in Clipboard
Editorial
Docetaxel, cisplatin, and fluorouracil in gastric cancer: does the punishment fit the crime?
J Clin Oncol.
.
No abstract available
Comment on
-
Clinical benefit with docetaxel plus fluorouracil and cisplatin compared with cisplatin and fluorouracil in a phase III trial of advanced gastric or gastroesophageal cancer adenocarcinoma: the V-325 Study Group.J Clin Oncol. 2007 Aug 1;25(22):3205-9. doi: 10.1200/JCO.2006.10.4968. J Clin Oncol. 2007. PMID: 17664467 Clinical Trial.
-
Quality of life with docetaxel plus cisplatin and fluorouracil compared with cisplatin and fluorouracil from a phase III trial for advanced gastric or gastroesophageal adenocarcinoma: the V-325 Study Group.J Clin Oncol. 2007 Aug 1;25(22):3210-6. doi: 10.1200/JCO.2006.08.3956. J Clin Oncol. 2007. PMID: 17664468 Clinical Trial.
Similar articles
-
Clinical benefit with docetaxel plus fluorouracil and cisplatin compared with cisplatin and fluorouracil in a phase III trial of advanced gastric or gastroesophageal cancer adenocarcinoma: the V-325 Study Group.J Clin Oncol. 2007 Aug 1;25(22):3205-9. doi: 10.1200/JCO.2006.10.4968. J Clin Oncol. 2007. PMID: 17664467 Clinical Trial.
-
Quality of life with docetaxel plus cisplatin and fluorouracil compared with cisplatin and fluorouracil from a phase III trial for advanced gastric or gastroesophageal adenocarcinoma: the V-325 Study Group.J Clin Oncol. 2007 Aug 1;25(22):3210-6. doi: 10.1200/JCO.2006.08.3956. J Clin Oncol. 2007. PMID: 17664468 Clinical Trial.
-
[Docetaxel-Cisplatin-5-Fu Combination Chemotherapy as a First-line Treatment in Patients with Metastatic or Recurred Gastric Cancer].Korean J Gastroenterol. 2007 Sep;50(3):207-209. Korean J Gastroenterol. 2007. PMID: 18975451 Korean. No abstract available.
-
Chemotherapy for advanced gastric or gastroesophageal cancer: defining the contributions of docetaxel.Expert Opin Pharmacother. 2006 Aug;7(12):1627-31. doi: 10.1517/14656566.7.12.1627. Expert Opin Pharmacother. 2006. PMID: 16872265 Review.
-
[Clinical development of chemotherapy for advanced gastric cancer].Nihon Shokakibyo Gakkai Zasshi. 2007 Feb;104(2):186-93. Nihon Shokakibyo Gakkai Zasshi. 2007. PMID: 17283412 Review. Japanese. No abstract available.
Cited by
-
A phase 2 study of SP1049C, doxorubicin in P-glycoprotein-targeting pluronics, in patients with advanced adenocarcinoma of the esophagus and gastroesophageal junction.Invest New Drugs. 2011 Oct;29(5):1029-37. doi: 10.1007/s10637-010-9399-1. Epub 2010 Feb 24. Invest New Drugs. 2011. PMID: 20179989 Clinical Trial.
-
Advances in the pharmacological treatment of gastro-oesophageal cancer.Drugs Aging. 2009;26(8):627-46. doi: 10.2165/11315740-000000000-00000. Drugs Aging. 2009. PMID: 19685930 Review.
-
Randomised phase II trial of docetaxel and sunitinib in patients with metastatic gastric cancer who were previously treated with fluoropyrimidine and platinum.Br J Cancer. 2012 Apr 24;106(9):1469-74. doi: 10.1038/bjc.2012.100. Epub 2012 Mar 29. Br J Cancer. 2012. PMID: 22460270 Free PMC article. Clinical Trial.
-
The BC Cancer Agency Compassionate Access Program: outcome analysis of patients with esophagogastric cancer.Curr Oncol. 2009 Sep;16(5):9-14. doi: 10.3747/co.v16i5.369. Curr Oncol. 2009. PMID: 19862357 Free PMC article.
-
Metachronous rectum metastases from gastric adenocarcinoma: a case report.Case Rep Med. 2012;2012:726841. doi: 10.1155/2012/726841. Epub 2012 Nov 25. Case Rep Med. 2012. PMID: 23251182 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
